Step-down versus step-up analgesics in patients with (sub)acute sciatica in primary care.
Suspended
- Conditions
- Sciatica, Pain medication, Cost-effectiveness
- Registration Number
- NL-OMON26984
- Lead Sponsor
- Erasmus MC, Erasmus Medical Center Rotterdam, departement of General Practice
- Brief Summary
A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- Not specified
- Target Recruitment
- 234
Inclusion Criteria
Patients will be eligible for inclusion if they:
1. Are aged 18 to 65 years
Exclusion Criteria
A patient who meets any of the following criteria will be excluded from participation in this study:
1. An episode of radiating (pain) complaints occurred in the preceding 6 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain severity of the leg (11 point numerical rating scale; higher score means more pain) measured daily over a period of 6 weeks follow-up.
- Secondary Outcome Measures
Name Time Method 1. Adverse reactions, systematically recorded in the questionnaires at follow-up measurements.<br /><br>2. Costs; all direct medical and patient costs and productivity costs.<br /><br>3. Quality of life.<br /><br>4. Patients’ perceived recovery.<br /><br>5. Patients’ perceived comfort during tapering of the medication.<br /><br>6. Disability measured with the Roland Disability Questionnaire for sciatica.<br /><br>7. Pain severity of the low back.<br /><br>8. Number of days with a severity of leg pain score of 7 or more.<br /><br>9. Compliance to treatment.<br /><br>10. Use of ‘rescue medication’.<br /><br>11. Patients’ satisfaction.<br /><br>12. Co-interventions will systematically be recorded in the questionnaires at follow-up measurements. <br />